Cite
Kolodkin-Gal D, Roitman L, Ovadya Y, et al. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions. Gut. 2021;71(2):345-355doi: 10.1136/gutjnl-2020-321112.
Kolodkin-Gal, D., Roitman, L., Ovadya, Y., Azazmeh, N., Assouline, B., Schlesinger, Y., Kalifa, R., Horwitz, S., Khalatnik, Y., Hochner-Ger, A., Imam, A., Demma, J. A., Winter, E., Benyamini, H., Elgavish, S., Khatib, A. A., Meir, K., Atlan, K., Pikarsky, E., Parnas, O., Dor, Y., Zamir, G., Ben-Porath, I., & Krizhanovsky, V. (2022). Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions. Gut, 71(2), 345-355. https://doi.org/10.1136/gutjnl-2020-321112
Kolodkin-Gal, Dror, et al. "Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions." Gut vol. 71,2 (2022): 345-355. doi: https://doi.org/10.1136/gutjnl-2020-321112
Kolodkin-Gal D, Roitman L, Ovadya Y, Azazmeh N, Assouline B, Schlesinger Y, Kalifa R, Horwitz S, Khalatnik Y, Hochner-Ger A, Imam A, Demma JA, Winter E, Benyamini H, Elgavish S, Khatib AA, Meir K, Atlan K, Pikarsky E, Parnas O, Dor Y, Zamir G, Ben-Porath I, Krizhanovsky V. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions. Gut. 2022 Feb;71(2):345-355. doi: 10.1136/gutjnl-2020-321112. Epub 2021 Mar 01. PMID: 33649045.
Copy
Download .nbib